Financial Ratios

MEDINOVA DIAGNOSTIC SERVICES LTD.

NSE : NABSE : 526301ISIN CODE : INE047C01019Industry : Hospital & Healthcare ServicesHouse : Private
BSE30.67-0.62 (-1.98 %)
PREV CLOSE ( ) 31.29
OPEN PRICE ( ) 30.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1347
TODAY'S LOW / HIGH ( )30.67 30.70
52 WK LOW / HIGH ( ) 17.264.5
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.632.082.18-0.300.77
   CEPS(Rs)0.872.342.500.121.33
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-2.84-3.48-5.58-7.71-7.41
   Tax Rate(%)27.6418.795.53-9.5630.42
Margin Ratios
   Core EBITDA Margin(%)19.1026.4623.235.514.52
   EBIT Margin(%)19.0626.1322.992.8022.78
   Pre Tax Margin(%)11.2222.1820.26-4.9116.37
   PAT Margin (%)8.1218.0119.14-5.3811.39
   Cash Profit Margin (%)11.1520.2721.982.1219.57
Performance Ratios
   ROA(%)10.6440.1255.05-8.0218.69
   ROE(%)0.000.000.000.000.00
   ROCE(%)56.880.000.000.000.00
   Asset Turnover(x)1.312.232.881.491.64
   Sales/Fixed Asset(x)1.882.972.591.121.39
   Working Capital/Sales(x)-4.66-5.61-2.29-0.82-1.05
Efficiency Ratios
   Fixed Capital/Sales(x)0.530.340.390.890.72
   Receivable days27.6420.2017.3923.3315.37
   Inventory Days6.544.693.134.353.71
   Payable days891.10569.501146.052034.021453.94
Valuation Parameters
   PER(x)27.7415.1710.530.0033.77
   PCE(x)20.1913.489.17121.5319.66
   Price/Book(x)-6.17-9.07-4.10-1.84-3.52
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)2.913.122.243.334.50
   EV/Core EBITDA(x)13.1910.998.6832.3264.03
   EV/EBIT(x)15.2911.949.75118.9819.77
   EV/CE(x)3.925.915.965.078.07
   M Cap / Sales2.252.732.012.583.85
Growth Ratio
   Net Sales Growth(%)-32.621.75106.01-18.540.88
   Core EBITDA Growth(%)-47.5411.81416.5419.34278.67
   EBIT Growth(%)-50.8315.641592.39-89.99209.91
   PAT Growth(%)-69.62-4.23832.40-138.502604.23
   EPS Growth(%)-69.63-4.23832.40-138.502604.11
Financial Stability Ratios
   Total Debt/Equity(x)-2.03-1.66-0.59-0.57-0.61
   Current Ratio(x)0.470.500.250.090.12
   Quick Ratio(x)0.430.460.230.080.11
   Interest Cover(x)2.436.628.430.363.55
   Total Debt/Mcap(x)0.330.180.140.310.17

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.